ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Neurology

Top Neurology Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BHUPENDRA SHAH M.D.

Neurology

7,500

$1.28M

640
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$170
Average prescription price

Avg: $223

STEVEN MAYNARD M.D.

Neurology

7,486

$1.68M

637
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 24%

$224
Average prescription price

Avg: $223

KEVIN KRISTL M.D.

Neurology

7,217

$1.8M

506
181 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$250
Average prescription price

Avg: $223

GUST SPENOS MD

Neurology

6,983

$904K

573
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$130
Average prescription price

Avg: $223

RICHARD SILBERMAN MD

Neurology

6,212

$1.01M

544
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$163
Average prescription price

Avg: $223

RODERICK WARREN M.D.

Neurology

5,436

$1.62M

478
256 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$298
Average prescription price

Avg: $223

JOHN WINIKATES M.D.

Neurology

5,333

$804K

494
253 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$151
Average prescription price

Avg: $223

AJAY GUPTA M.D.

Neurology

5,129

$3.47M

448
215 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$677
Average prescription price

Avg: $223

JOHN CHASE MD

Neurology

4,888

$808K

462
272 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$165
Average prescription price

Avg: $223

MICHAEL SERMERSHEIM MD

Neurology

4,834

$977K

408
209 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$202
Average prescription price

Avg: $223

THOMAS VIDIC M.D.

Neurology

4,827

$985K

455
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$204
Average prescription price

Avg: $223

JOHN MUNSHOWER MD

Neurology

4,795

$944K

512
337 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$197
Average prescription price

Avg: $223

USMAN SIDDIQUI MD

Neurology

4,666

$420K

222
74 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $223

SUYING WU M.D.

Neurology

4,578

$609K

511
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $223

JOHN STURMAN M.D.

Neurology

4,518

$574K

295
32 are 65+

86%
patients receiving schedule two controlled substances

Avg: 4%

31%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $223

JEFFREY HAGEDORN M.D.

Neurology

4,500

$735K

490
300 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$163
Average prescription price

Avg: $223

JOANNE WOJCIESZEK MD

Neurology

4,417

$723K

270
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$164
Average prescription price

Avg: $223

MRIDULA PRASAD M.D.

Neurology

4,244

$2.71M

275
107 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$638
Average prescription price

Avg: $223

PATRICK RUSSELL D.O.

Neurology

4,177

$857K

342
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$205
Average prescription price

Avg: $223

DAVID MATTSON MD

Neurology

4,016

$3.17M

220
43 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$788
Average prescription price

Avg: $223

DONALD HARRIS M.D.

Neurology

3,795

$427K

384
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $223

NANCY FRAPPIER MD

Neurology

3,769

$1.29M

430
291 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$343
Average prescription price

Avg: $223

KYLENE HULER M.D.

Neurology

3,765

$1M

319
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$266
Average prescription price

Avg: $223

THOMAS BANAS M.D.

Neurology

3,623

$949K

431
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$262
Average prescription price

Avg: $223

ANTHONY SIMCHAK MD

Neurology

3,577

$739K

337
229 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$207
Average prescription price

Avg: $223

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank